AbbVie competitors
AbbVie Competitors include Johnson & Johnson, Roche, Novartis, GlaxoSmithKline and MyoKardia.
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  AbbVie AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs. |  Johnson & Johnson Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field. |  MyoKardia MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. | |||
Founding Date | Founding Date 2013 | Founding Date 1886 | Founding Date 1896 | Founding Date 1996 | Founding Date 2000 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||
Locations | Locations North Chicago, US HQ Ludwigshafen, DE Sligo, IE Cork, IE Campoverde, IT Tokyo, JP Jayuya, PR see more | Locations New Brunswick, US HQ Buenos Aires, AR Yerevan, AM Broadway, AU Dhaka, BD Minsk, BY Machelen, BE see more | Locations Basel, CH HQ South San Francisco, US | Locations Brentford, GB HQ | Locations South San Francisco, US HQ | |
Employees | Employees 29,000 | Employees 134,0006% increase | Employees 93,734 | Employees 126,0004% increase | Employees 98,462 | Employees 1024% increase |
Valuation ($) | Valuation ($) 137.3 b | Valuation ($) 359.1 b | Valuation ($) N/A | Valuation ($) 175.5 b | Valuation ($) 101.9 b | Valuation ($) 2 b |
Facebook likes | Facebook likes 11.9 k | Facebook likes 776.4 k | Facebook likes 80.2 k | Facebook likes 304.3 k | Facebook likes 273 k | Facebook likes N/A |
Twitter followers | Twitter followers 48.3 k | Twitter followers 90.5 k | Twitter followers 177.2 k | Twitter followers 234.4 k | Twitter followers 163.4 k | Twitter followers 387 |
Financial ⚠ | ||||||
Revenue (est.) | Revenue (est.) $25.6b (FY, 2016) | Revenue (est.) $76.5b (FY, 2017) | Revenue (est.) CHF48.1b (FY, 2015) | Revenue (est.) $49.1b (FY, 2017) | Revenue (est.) £30.2b (FY, 2017) | Revenue (est.) $22.5m (FY, 2017) |
Cost of goods | Cost of goods $5.8b (FY, 2016) | Cost of goods $25.4b (FY, 2017) | Cost of goods CHF15.5b (FY, 2015) | Cost of goods $17.2b (FY, 2017) | Cost of goods £10.3b (FY, 2017) | Cost of goods N/A |
Gross profit | Gross profit $19.8b (FY, 2016) | Gross profit $51.1b (FY, 2017) | Gross profit CHF32.7b (FY, 2015) | Gross profit $31.9b (FY, 2017) | Gross profit £19.8b (FY, 2017) | Gross profit N/A |
Net income | Net income $6b (FY, 2016) | Net income $1.3b (FY, 2017) | Net income CHF9.1b (FY, 2015) | Net income $7.7b (FY, 2017) | Net income £2.2b (FY, 2017) | Net income ($46m) (FY, 2017) |
Operating ⚠ | ||||||
Countries | Countries N/A | Countries 60 (FY, 2017) | Countries N/A | Countries N/A | Countries 100 (FY, 2016) | Countries N/A |
Drugs Approved by FDA | Drugs Approved by FDA N/A | Drugs Approved by FDA 2 (FY, 2015) | Drugs Approved by FDA 2 (Y, 2015) | Drugs Approved by FDA N/A | Drugs Approved by FDA N/A | Drugs Approved by FDA N/A |
Major Approvals (US, EU, JP) | Major Approvals (US, EU, JP) N/A | Major Approvals (US, EU, JP) N/A | Major Approvals (US, EU, JP) 12 (Y, 2016) | Major Approvals (US, EU, JP) 16 (Y, 2016) | Major Approvals (US, EU, JP) N/A | Major Approvals (US, EU, JP) N/A |
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities 125 (FY, 2017) | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 87 (FY, 2016) | Manufacturing Facilities N/A |
US FDA Breakthrough Therapy Designations | US FDA Breakthrough Therapy Designations N/A | US FDA Breakthrough Therapy Designations N/A | US FDA Breakthrough Therapy Designations 5 (Y, 2016) | US FDA Breakthrough Therapy Designations 5 (Y, 2016) | US FDA Breakthrough Therapy Designations N/A | US FDA Breakthrough Therapy Designations N/A |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised $ 98m |
For sources of this data, please see the company profileDownload Excel
View company profiles
Johnson & Johnson
HQ
New Brunswick, US
Employees
134,000↑ 6% increase
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
View company
Roche
HQ
Basel, CH
Employees
93,734
Roche Holding is a diagnostics and pharmaceutical company.
View company
Novartis
HQ
Basel, CH
Employees
126,000↑ 4% increase
Novartis researches, develops, manufactures, and markets a range of healthcare products.
View company
GlaxoSmithKline
HQ
Brentford, GB
Employees
98,462
GlaxoSmithKline is a science-led healthcare company.
View company